TF

Topspin Fund

North America, New York, United States, Mamaroneck

Description

Topspin Fund is a venture capital firm that primarily invests in biotech sectors.

Investor Profile

Topspin Fund has made 7 investments, with 0 in the past 12 months and 29% as lead.

Stage Focus

  • Series Unknown (43%)
  • Series A (14%)
  • Series C (14%)
  • Seed (14%)
  • Series D (14%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Therapeutics
  • Pharmaceutical
  • Biopharma
  • Medical Device
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Topspin Fund frequently co-invest with?

Shangbay Capital
North America, California, United States, Palo Alto
Co-Investments: 2
Richard King Mellon Foundation
North America, Pennsylvania, United States, Pittsburgh
Co-Investments: 2
EC
North America, New York, United States, New York
Co-Investments: 2
Catalio Capital Management
North America, New York, United States, New York
Co-Investments: 2
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 2
Boston Scientific
North America, Massachusetts, United States, Marlborough
Co-Investments: 2
AC
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 2
Morgenthaler Ventures
North America, California, United States, Menlo Park
Co-Investments: 2
Citta Capital
North America, California, United States, Palo Alto
Co-Investments: 2
Action Potential Venture Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 2

What are some of recent deals done by Topspin Fund?

Neuvotion

Darien, Connecticut, United States

Neuvotion is a medical device company developing neurostimulation products for the rehabilitation and physical therapy markets.

Health Care
SeedApr 13, 2023
Amount Raised: $1,250,000
SetPoint Medical

Valencia, California, United States

SetPoint Medical develops novel therapeutics for the treatment of chronic autoimmune conditions.

BiotechnologyHealth CareMedicalTherapeutics
Series UnknownJan 19, 2023
Amount Raised: $80,000,000
DepYmed

Farmingdale, New York, United States

DepYmed is a disease therapeutic development company that develops potent inhibitors of the enzyme PTP1B.

BiotechnologyHealth CareMedical
Series UnknownApr 13, 2021
Amount Raised: $8,300,000
SetPoint Medical

Valencia, California, United States

SetPoint Medical develops novel therapeutics for the treatment of chronic autoimmune conditions.

BiotechnologyHealth CareMedicalTherapeutics
Series UnknownJan 27, 2021
Amount Raised: $64,000,000
ORIC Pharmaceuticals

South San Francisco, California, United States

ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.

BiopharmaBiotechnologyHealth CarePharmaceuticalTherapeutics
Series CFeb 21, 2018
Amount Raised: $50,000,000
DepYmed

Farmingdale, New York, United States

DepYmed is a disease therapeutic development company that develops potent inhibitors of the enzyme PTP1B.

BiotechnologyHealth CareMedical
Series AOct 26, 2016
Amount Raised: $2,000,000
Peloton Therapeutics

Dallas, Texas, United States

Peloton Therapeutics, a biotech company based in Dallas, is involved in discovering and developing novel drugs for cancer treatments.

BiotechnologyHealth CareMedical DeviceOncologyPharmaceuticalTherapeutics
Series DSep 15, 2016
Amount Raised: $52,400,000